XML 17 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 4,278,124 $ 11,608,855
Restricted cash (note 3) 8,253 10,905
Short-term investments (note 4) 7,034,569 1,806,449
Accounts receivable - net (note 6) 537,118 952,402
Inventories (note 7) 180,719 375,511
Prepaid expenses and deposits 15,242 160,987
Income tax receivable 72,371  
Total current assets 12,126,396 14,915,109
Property, plant and equipment - net (note 8) 993,781 903,298
Prepaid land lease payments (note 9) 69,815 39,730
Intangible assets - net (note 10) 9,699 1,480
Long-term prepaid expenses (note 13(b)) 23 25
Long-term investments (note 4) 661,440 655,835
Prepayments for acquisition of equipment 120,912 65,290
Deferred tax assets (note 15) 71,118 52,031
Right-of-use assets (notes 11 and 13(b)) 58,586 115,376
Other non-current assets 2,798  
Total assets 14,114,568 16,748,174
Current liabilities    
Short-term bank loans and current portion of long-term bank loans (note 12) 293 3,099
Loan from a non-controlling shareholder (note 13 (a)) 4,358 1,582
Accounts payable and accrued liabilities (note 14) 905,923 1,020,651
Income tax payable   1,267,504
Deferred revenue (note 16) 17,955 79,941
Deferred government grants (note 17) 15,120 12,559
Dividend payable (note 19) 141,993 17,125
Lease liability (notes 11 and 13(b)) 5,993 10,385
Total current liabilities 1,091,635 2,412,846
Deferred government grants (note 17) 4,477 4,870
Long-term bank loans (note 12) 11,513 12,668
Deferred tax liability 241,526 324,164
Loan from a non-controlling shareholder (note 13 (a))   4,708
Lease liability (notes 11 and 13(b)) 52,516 112,465
Other non-current liabilities (note 15) 240 444
Total long-term liabilities 310,272 459,319
Total liabilities 1,401,907 2,872,165
Commitments and contingencies (notes 18 and 24)
EQUITY    
Preferred stock (note 19) Authorized 50,000,000 shares at par value of $0.001 each Issued and outstanding: 14,630,813, including 14,630,813 held in trust (2021 - 14,630,813, 14,630,813) 15 15
Common stock (note 19) Authorized: 100,000,000 shares at par value of $0.001 each Issued and outstanding: 99,502,243, including 27,777,341 held in trust (2021 - 99,502,243, 27,777,341 ) 100 100
Additional paid-in capital 540,582 547,691
Subscriptions receivable   (7,109)
Accumulated other comprehensive income (loss) (383,276) 130,622
Statutory surplus reserves (note 21) 1,538,013 1,514,297
Accumulated earnings 7,225,987 7,141,819
Total shareholders' equity 8,921,421 9,327,435
Non-controlling interests 3,791,240 4,548,574
Total equity 12,712,661 13,876,009
Total liabilities and equity $ 14,114,568 $ 16,748,174